-PTI The government has decided to put on hold allocation of mines having minerals other than coal in view of the Mines and Minerals Bill pending before Parliament. The Prime Minister's Office (PMO) sent a directive in this regard to the Mines Ministry about two months back, sources said here today. The Mines Ministry was advised that since the Mines and Minerals (Regulation and Development) Bill 2011 had not been passed by Parliament...
More »SEARCH RESULT
Total Matching Records found : 1041
Protest against new Land Acquisition Bill
-Pratirodh.com NAPM on Tuesday started a three-day demonstration at Jantar Mantar in Delhi to protest against the draft Land Acquisition Bill and demanded revision of the draft to incorporate changes suggested by a Parliamentary panel and civil society. NAPM has organised the dharna in association with several other land rights and anti-displacement movements — like the National Forum of Forest people,Mazdoor Kisan Shakti Sangathan and Forest workers — under the banner of...
More »1144 Deaths During Clinical Drug Trials in 2 Years: Govt
-PTI Clinical drug trials in India led to the death of 1144 people in 2010 and 2011, the government today said. The number of people dying during such trials also include 1106 people whose death could be attributed to diseases like cancer, terminal illness or various unrelated causes which is also known as Serious Adverse Event (SAE) of death, Health and Family Welfare Minister Ghulam Nabi Azad told the Rajya Sabha. "The number...
More »Basudeb Acharia, Chairman of the Parliamentary Standing Committee on Agriculture interviewed by Gargi Parsai
-The Hindu The debate on the pros and cons of genetically engineered/modified crops is universal. In India, in the face of vociferous protests, the controversy has only deepened leading to a moratorium on cultivation of Bt Brinjal crop — the first GM food crop sought to be commercialised. Gargi Parsai spoke to Basudeb Acharia, Chairman of the Parliamentary Standing Committee on Agriculture, on its new report, “Cultivation of Genetically Modified Food...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
